Johnson & Johnson.
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
J&J Reports Q3 Results, Adjusts 2026 Outlook
J&J Q3 non-GAAP EPS hit $2.59, beating the $2.53 estimate, with $25.4B revenue slightly above consensus; the firm adjusted 2026 guidance and set a $1.34 Q4 dividend.
Business · 19 sources · Oct 13, 2026Read it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About Johnson & Johnson
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 42 on the 2026 Fortune 500 list of the largest United States corporations. In 2026, the company was ranked 43rd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
Everything about Johnson & Johnson →- Country
- United States, United Kingdom
- Headquarters
- New Brunswick
- Inception
- 1886
- Website
- https://www.jnj.com, http://www.jjmt.com.tw/, http://www.jnj.com.cn, https://www.jnj.com.hk/